This stock has reverse split written all over it. 200M+ in the float. I'll check back after the product is on the market and the reverse split is out of the way!
CYCR ($0.41). 275M shares outstanding. Marketing a replacement to the pap smear - a $5B to $6B industry. If they could grab even $1B of that and pocket $300M of the $1B after taxes - you have a $15 stock. I don't own any right now. Just glanced at the research report tonight.
I took PRVB's advice: PRVB- thanks for the shout out on CYCR. Took a position last week after your table pound and I'm up 25%. More importantly, this looks like it may be the solution to the "inconclusive" or "erroneous" PAP smears the women in my family have endured for years. Win-Win for all. Thanks again.
News 
Market Data 
Discover 
AI
